BUR1

CAS No. 23000-46-6

BUR1( BUR-1 | BUR 1 | BMP upregulator 1 | BMP upregulator-1 )

Catalog No. M27759 CAS No. 23000-46-6

BUR1 is a Saccharomyces cerevisiae cyclin-dependent kinase (CDK) and is homologous to mammalian Cdk9, which functions in transcriptional elongation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 302 In Stock
5MG 319 In Stock
10MG 472 In Stock
25MG 753 In Stock
50MG 1051 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BUR1
  • Note
    Research use only, not for human use.
  • Brief Description
    BUR1 is a Saccharomyces cerevisiae cyclin-dependent kinase (CDK) and is homologous to mammalian Cdk9, which functions in transcriptional elongation.
  • Description
    BUR1 is a Saccharomyces cerevisiae cyclin-dependent kinase (CDK) and is homologous to mammalian Cdk9, which functions in transcriptional elongation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    BUR-1 | BUR 1 | BMP upregulator 1 | BMP upregulator-1
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    SETD2
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23000-46-6
  • Formula Weight
    279.347
  • Molecular Formula
    C16H17N5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1CCN(CC1)c1ncnc2n(ncc12)-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jennifer Totman, et al. Pharmacologic Inhibition of the Histone Methyltransferase SETD2 with EZM0414 As a Novel Therapeutic Strategy in Relapsed or Refractory Multiple Myeloma and Diffuse Large B-cell Lymphoma.
molnova catalog
related products
  • JSH-150

    JSH-150 (JSH150) is a potent, highly selective inhibitor of CDK9 kinase with IC50 of 1 nM in the biochemical assays, displays 300-10000-fold selectivity over other CDK kinase family members (CDK7 IC50=1.72 uM).

  • Purvalanol B

    A potent, cell-permeable, selective inhibitor of CDK with IC50s of 6, 6, 9, and 6 nM for cdc2/cyclin B, cdk2/cyclin A, cdk2/cyclin E, and cdk5-p35 respectively.

  • Mevociclib

    Mevociclib is a highly selective covalent inhibitor of CDK7. SY-1365 possesses therapeutic potential in both hematological and solid tumors.